A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout ...

A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...

A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in ...

Discovery of inhibitors that suppress disease-specific keratinocyte death and demonstration of their efficacy in preclinical ...

Entrepreneur and podcaster Steven Bartlett’s holding company, Steven.com, has been valued at $425m (£320m) after securing ...

Niigata, Japan - A collaborative research group led by Haruna Kimura (graduate student), Dr. Akito Hasegawa (Assistant Professor), and Prof. Riichiro ...

Results from the pivotal EV-303 trial demonstrated that, when used before and after surgery, the combination reduced the risk of recurrence, progression or death by 60% and the risk of death by 50% in ...

Phathom will showcase its growing leadership in GI through multiple engagements with the medical and scientific community, including a product theater presentation highlighting VOQUEZNA ® (vonoprazan) ...

Detailed price information for Phathom Pharmaceuticals Inc (PHAT-Q) from The Globe and Mail including charting and trades.

Researchers say ophthalmologists and optometrists were motivated, at least in part, to use the sutureless grafts for dry eye disease by the profit margin they make on devices.

DOR/ISL data presented show minimal changes in weight and body composition and no clinically meaningful effect on fasting lipids and the homeostatic model assessment of insulin resistance (HOMA-IR) ...